中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2015年
1期
5-7
,共3页
马彩艳%童鸿%谢培怡%李小玲%叶建华
馬綵豔%童鴻%謝培怡%李小玲%葉建華
마채염%동홍%사배이%리소령%협건화
温阳方%慢性心力衰竭%β受体阻滞剂%临床疗效
溫暘方%慢性心力衰竭%β受體阻滯劑%臨床療效
온양방%만성심력쇠갈%β수체조체제%림상료효
Wenyangfang%chronic heart failure%clinical effect
目的:探讨温阳方联合西药治疗慢性心力衰竭( CHF)的临床疗效。方法70例CHF 患者随机分温阳方+西药治疗组35例(试验组)和西药治疗组35例(对照组)。对照组给予降血压、β受体阻滞剂、利尿剂、强心等药物治疗;试验组在对照组的基础上予以温阳方,2组患者治疗1个月。治疗1个月后评价2组患者神经内分泌指标及左室射血分数(LVEF)。结果治疗1个月后,试验组与对照组血浆去甲肾上腺素(NE)、血管紧张素Ⅱ(AngⅡ)和醛固醇(ALD)均明显降低(P <0.05),左室射血分数(LVEF)均显著升高(P <0.05),但试验组与对照组相比变化更为显著(P <0.05)。治疗后试验组总有效率显著高于对照组(P <0.05)。结论温阳方联合西药治疗CHF 可显著提高LVEF,改善心力衰竭症状。
目的:探討溫暘方聯閤西藥治療慢性心力衰竭( CHF)的臨床療效。方法70例CHF 患者隨機分溫暘方+西藥治療組35例(試驗組)和西藥治療組35例(對照組)。對照組給予降血壓、β受體阻滯劑、利尿劑、彊心等藥物治療;試驗組在對照組的基礎上予以溫暘方,2組患者治療1箇月。治療1箇月後評價2組患者神經內分泌指標及左室射血分數(LVEF)。結果治療1箇月後,試驗組與對照組血漿去甲腎上腺素(NE)、血管緊張素Ⅱ(AngⅡ)和醛固醇(ALD)均明顯降低(P <0.05),左室射血分數(LVEF)均顯著升高(P <0.05),但試驗組與對照組相比變化更為顯著(P <0.05)。治療後試驗組總有效率顯著高于對照組(P <0.05)。結論溫暘方聯閤西藥治療CHF 可顯著提高LVEF,改善心力衰竭癥狀。
목적:탐토온양방연합서약치료만성심력쇠갈( CHF)적림상료효。방법70례CHF 환자수궤분온양방+서약치료조35례(시험조)화서약치료조35례(대조조)。대조조급여강혈압、β수체조체제、이뇨제、강심등약물치료;시험조재대조조적기출상여이온양방,2조환자치료1개월。치료1개월후평개2조환자신경내분비지표급좌실사혈분수(LVEF)。결과치료1개월후,시험조여대조조혈장거갑신상선소(NE)、혈관긴장소Ⅱ(AngⅡ)화철고순(ALD)균명현강저(P <0.05),좌실사혈분수(LVEF)균현저승고(P <0.05),단시험조여대조조상비변화경위현저(P <0.05)。치료후시험조총유효솔현저고우대조조(P <0.05)。결론온양방연합서약치료CHF 가현저제고LVEF,개선심력쇠갈증상。
Objective To evaluate the clinical effects of Wenyang in the treatment of chronic heart failure ( CHF ) .Methods Seventy patients with CHF were recruited and randomly divided into experiment group ( n=35 ) and control group ( n=35 ) .Patients in the experiment group were treated with Wenyangfang and west medicine;patients in the control group were treated with west medicine only.All the patients were treated 1 month.After 1 month treatment, the neuroendocrine indicators and LVEF were compared between the two groups.Results After treatment of 1 month, the norepinephrine, angiotensin Ⅱ( AngⅡ) , aldosterone ( ALD ) were decreased in both experiment and control group ( P <0.05), the left ventricular ejection fraction(LVEF) was both improved in the two groups.And the experiment group was much significant than that of control group ( P <0.05 ) .The total efficacy in the experiment group was much higher than that of control group ( P <0.05 ) . Conclusion Wenyangfang combined with the medicine can significant improve the LVEF and symptom in patients with CHF.